Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Rectogesic rejected by SMC

The Scottish Medicines Consortium has rejected Glyceryl Trinitrate 0.4% Ointment (Rectogesic) for use in Scotland.

The advice issued by the Consortium agrees that this product lowers pain scores more than a placebo ointment but they felt the effect was small and that an economic case for use was not demonstrated. This economic case was made based up healing rates compared to surgery, but rectogesic is not licensed to heal anal fissures.

Action: Symptomatic treatment of anal fissures at presentation should be based on lifestyle advice about diet and bowel habit. Prescriptions for products containing topical steroids or anaesthetics may be appropriate for management of pain and inflammation.

Share 'Rectogesic rejected by SMC' on Email Share 'Rectogesic rejected by SMC' on Delicious Share 'Rectogesic rejected by SMC' on Digg Share 'Rectogesic rejected by SMC' on Facebook Share 'Rectogesic rejected by SMC' on Google+ Share 'Rectogesic rejected by SMC' on reddit Share 'Rectogesic rejected by SMC' on StumbleUpon Share 'Rectogesic rejected by SMC' on Twitter

atomic-wealth

One Comments to “Rectogesic rejected by SMC”

  1. […] This latest advice is based upon a resubmission of data after the SMC had rejected the product last year as reported here. […]

    Pingback by SMC Reject Rectogesic | Prescribing Advice For GPs — April 11, 2006 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,599 spam comments.

atomic-wealth
fond-illness
summer